Stay updated on Pembrolizumab in RCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in RCC Clinical Trial page.

Latest updates to the Pembrolizumab in RCC Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.6.6 was added, replacing the previous v3.6.5. This reflects an update to the page's revision metadata rather than changes to the study data.SummaryDifference0.1%

- Check18 days agoChange DetectedThe study's identifiers section includes a new line documenting an NIH grant/contract (2016). This addition records funding information as part of the study's administrative identifiers.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing the previous revision and indicating deployment of the latest site build.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4 in the page footer, representing an internal software update. The public study details and navigation remain unchanged.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, reflecting a new version of the page's documentation. It does not modify the study content or any user-facing information on the page.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision badge at the bottom of the page updated from v3.6.0 to v3.6.2, signaling a new build of the page rendering. This update is a minor template/page maintenance change and does not affect study details or user-facing content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in RCC Clinical Trial page.